Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.

Andus, T; Gross, V; Caesar, I; Schulz, H J; Lochs, H; Strohm, W D; Gierend, M; Weber, A; Ewe, K; Schölmerich, J

Andus, T; Gross, V; Caesar, I; Schulz, H J; Lochs, H; Strohm, W D; Gierend, M; Weber, A; Ewe, K; Schölmerich, J.

Affiliation

Andus T; Klinikum Stuttgart, Krankenhaus Bad Cannstatt, Stuttgart, Germany.

Dig Dis Sci ; 48(2): 373-8, 2003 Feb.

Article in En | MEDLINE | ID: mdl-12643618

Subject(s)

Budesonide/administration & dosage; Crohn Disease/diagnosis; Crohn Disease/drug therapy; Administration, Oral; Adult; Budesonide/adverse effects; Delayed-Action Preparations/administration & dosage; Delayed-Action Preparations/adverse effects; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids/administration & dosage; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa/drug effects; Intestinal Mucosa/pathology; Male; Middle Aged; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Budesonide Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Dig Dis Sci Year: 2003 Document type: Article Affiliation country: Germany Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links